Press Releases

 
Press Releases
  Date Title View
Jul 28, 2016
Second Quarter Revenue Increased 64% Versus Prior Year to $12.5 millionePlex® Systems Installed at Twelve European CustomersePlex FDA Submission Expected in Fourth Quarter CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of ...
PDF
Jul 27, 2016
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, President and Chief Executive Officer, will present at the 36th Annual Canaccord Genuity Growth Conference to be ...
PDF
Jul 14, 2016
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its second quarter earnings results after market close on Thursday, July 28, 2016. Management will hold a conference call to review the Company's financial performance starting at 4:30 p.m. ET on ...
PDF
Jun 8, 2016
European Customer Agreements in Place for Initial Systems CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced it has achieved CE Mark under the European In‐Vitro Di...
PDF
Jun 6, 2016
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, President and Chief Executive Officer, will present at the William Blair 36th Annual Growth Stock Conference to be ...
PDF
May 3, 2016
First Quarter Revenue Increased 9% Versus Prior Year to $11.1 millionePlex CE Mark Expected in Second Quarter CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today ...
PDF
Apr 19, 2016
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its first quarter earnings results after market close on Tuesday, May 3, 2016. Management will hold a conference call to review the Company's financial performance starting at 4:30 p.m. ET on the s...
PDF
Feb 23, 2016
Fourth Quarter Revenue increased 34% Versus Prior Year to $13.2 million Fourth Quarter Gross Margin Increased to 64%, and XT-8 Installed Base Grew by 17 to 633 ePlex Production Capacity Increased to Support Upcoming European Launch Additional Time ...
PDF
Jan 12, 2016
- Preliminary Fourth Quarter Revenue Increased 35% Versus Prior Year to $13.2 Million - XT-8 Installed Base Grew by 17 to 633 - Transfer to Manufacturing of ePlex Sample-to-Answer System Completed and Analytical Studies Commenced CARLSBAD, Calif.--(BU...
PDF
Dec 30, 2015
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, will present at the 2016 J.P. Morgan Healthcare Conference to be held at the Westin St. Francis Hotel in San Francisco, California on Wednesday, January 13...
PDF
1
...
NextLast